Patents by Inventor David STEGNER

David STEGNER has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Treatment and Prevention of Ischemic Diseases And/Or Ischemic Tissue Damages
    Publication number: 20220372159
    Abstract: The invention relates to a CD84 inhibitor for use in treating or preventing of an ischemic disease and/or ischemic tissue damage, the use of a CD84 inhibitor for inhibiting CD84 mediated T cell migration in vitro and a method for screening for a CD84 inhibitor.
    Type: Application
    Filed: July 1, 2020
    Publication date: November 24, 2022
    Applicant: Julius-Maximilians-Universitaet-Wuerzburg
    Inventors: Michael Schuhmann, Guido Stoll, Bernhard Nieswandt, David Stegner
  • Soluble glycoprotein V for treating thrombotic diseases
    Patent number: 11028144
    Abstract: A soluble polypeptide comprising a modified glycoprotein V (GPV) lacking a functional transmembrane domain for use in the treatment or prevention of a thrombotic disease in a subject, said treatment or prevention comprising administering to the subject an effective amount of said soluble polypeptide.
    Type: Grant
    Filed: December 23, 2016
    Date of Patent: June 8, 2021
    Assignee: JULIUS-MAXIMILIANS-UNIVERSITÄT WÜRZBURG
    Inventors: Bernhard Nieswandt, Sarah Beck, David Stegner
  • SOLUBLE GLYCOPROTEIN V FOR TREATING THROMBOTIC DISEASES
    Publication number: 20190169265
    Abstract: A soluble polypeptide comprising a modified glycoprotein V (GPV) lacking a functional transmembrane domain for use in the treatment or prevention of a thrombotic disease in a subject, said treatment or prevention comprising administering to the subject an effective amount of said soluble polypeptide.
    Type: Application
    Filed: December 23, 2016
    Publication date: June 6, 2019
    Inventors: Bernhard NIESWANDT, Sarah BECK, David STEGNER
  • GLYCOPROTEIN V INHIBITORS FOR USE AS COAGULANTS
    Publication number: 20190169307
    Abstract: The present invention relates to an inhibitor of platelet glycoprotein V (GPV) for use as a coagulant, and/or for use in the treatment or prevention of a hemorrhagic condition.
    Type: Application
    Filed: December 23, 2016
    Publication date: June 6, 2019
    Inventors: Bernhard NIESWANDT, Sarah BECK, David STEGNER